article thumbnail

RefleXion Acquires Global Rights to Radiopharmaceutical Molecule from 3B Pharmaceuticals to Treat High Unmet Need Cancers

Imaging Technology

We are excited, in collaboration with 3BP and others, to advance this molecule through clinical testing to commercialization.” milla1cf Wed, 09/20/2023 - 09:56 September 20, 2023 — RefleXion Medical , Inc., Our partnership with 3BP is as unprecedented in the external-beam radiotherapy industry as our SCINTIX therapy is for cancer treatment.

article thumbnail

The Benefits of Coronary CTA in Pharmaceutical Clinical Trials

Imaging Technology

Coronary computed tomography angiography (CCTA) is cheaper, easier to use and its results are easier to understand than Intravascular ultrasound (IVUS), making it ideal for clinical trials of cardi

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

First Participant Treated Using NorthStar Medical Radioisotopes’ Electron Accelerator-produced Copper-67 (Cu-67) in Clarity Pharmaceuticals’ Phase I/IIa Theranostic Clinical Trial Investigating Cu-67 SARTATE for Treatment of Neuroblastoma

Imaging Technology

Administration of the therapeutic dose took place as part of an ongoing Phase I/IIa theranostic clinical trial conducted by Clarity Pharmaceuticals to investigate the safety and efficacy of Cu-67 SARTATE in pediatric patients with high-risk neuroblastoma.

article thumbnail

How AI is Transforming the Pharmaceutical Industry

MRI Network

It’s also primed to revolutionize the pharmaceutical industry. Pharma companies that truly embrace AI can run parallel clinical trials for the same drug as a single agent or in combinations targeting multiple diseases where the drug is predicted to work. Many pharma companies have changed their CEOs at least once.

article thumbnail

The International Council for Harmonization (ICH) Q10: A Model for a Robust Pharmaceutical Quality Management System

Open Medscience

ICH Q10 is a global model for managing pharmaceutical quality, ensuring compliance, continuous improvement, and risk manage The post The International Council for Harmonization (ICH) Q10: A Model for a Robust Pharmaceutical Quality Management System appeared first on Open MedScience.

article thumbnail

GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)

Imaging Technology

Currently, when treating metastatic breast cancer patients, oncologists base clinical decisions on diagnostic tools including biopsy results which only represent the sampled area of the tumor. In the U.S., FES PET, like FDG PET, is now included in the NCCN Guidelines. The NCCN is a not-for-profit alliance of 33 leading U.S.

Clinic 94
article thumbnail

TeleDaaS Launches as Premier Provider of Dosimetry as a Service for Clinical Research Organizations

Imaging Technology

TeleDaaS specializes in delivering clinical-grade, precision-based dosimetry analysis and treatment plans to clinical research organizations (CROs) and pharmaceutical manufacturers. The life expectancy of patients on the personalized dosimetry arm of the trial increased to 26.6 months from 10.7

Clinic 78